Sandbox:Reddy
OUT Patient
Dysenteric Diarrhea
Frequent, sometimes bloody, small-volume diarrhea associated with abdominal pain and cramping. Patient may be febrile and toxic. |
Shigella
Salmonella Campylobacter Yersinia E. coli 0157:H7 'C.difficile' |
Ciprofloxacin 500 mg PO BID
OR Ciprofloxacin 750 mg daily x 3 days (avoid in cases of E. coli O157:H7 as it may increase the risk of hemolytic-uremic syndrome) Recent antibiotic exposure: consider C. difficile Antimotility drugs should not be used in C.difficile. C. difficile - Metronidazole 500 mg PO TID x 10-14 days. If no response at 5 days, switch to Vancomycin 125mg PO QID x10-14 days. See inpatient guidelines for severe or recurrent C. difficile infection and/or policy on C. difficile management. |
|
Nondysenteric Diarrhea
Large volume, nonbloody, watery diarrhea. Patient may have nausea, vomiting, and abdominal cramping but fever often absent. |
Viruses
Giardia Enterotoxigenic E. coli Enterotoxin-producing bacteria |
General Care: Observation
Oral rehydration Antimotility agents Giardia – especially if patient describes recent history of travel and/or ingestion of unfiltered water (e.g., camping), consider – Metronidazole 250 mg PO TID x 5 days. |
|
Traveler’s diarrhea
Empiric treatment while abroad |
Toxigenic E. coli
Salmonella Shigella Campylobacter Amebiasis |
Ciprofloxacin 500 mg PO BID x 1-3 days
Pregnancy or fluoroquinolone-resistant campylobacter: Azithromycin 1 g x 1 dose EITHER WITH or WITHOUT: Loperamide 4 mg PO x 1; then 2 mg after each loose stool, MAX 16 mg/day |
Mild, self-limited cases can be treated with fluid and electrolyte repletion and bismuth subsalicylate.
Prophylaxis generally not recommended. |
Diverticulitis | Enterobacteriaceae
Bacteroides fragilis 'Enterococcus' |
Amoxicillin/clavulanate
875 mg/125 mg PO BID OR MoxifloxacinID-R: SFGH 400 mg PO daily OR the combination of: Metronidazole 500 mg PO TID PLUS ONE OF: Ciprofloxacin 500 mg PO BID OR LevofloxacinID-R: VASF 500 mg PO daily |
Duration of treatment should be until patient is afebrile for 3-5 days.
Surgical evaluation and follow up is advised. |